Dompe S.P.A.
Records under this name other than patents Dompe S.P.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,039,656 | 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,268,594 | pyrC as a selection marker in Escherichia coli Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,388,972 | Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,133,911 | (R)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,624,036 | 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,906,946 | TRPM8 receptor antagonists Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,856,246 | TRPM8 antagonists Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,585,875 | TRPM8 antagonists Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,409,876 | Bradykinin receptor antagonists and pharmaceutical compositions containing them Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,846,755 | Sulfonamides for the Prevention of Diabetes Formerly held Lapsed on the fee record Ended Sep 30, 2026 · High confidence | Lapsed on the fee record | Ended Sep 30, 2026 | High confidence |